OBIO
Orchestra BioMedDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Positive clinical data and a strategic partnership materially de-risks the growth path, supporting ~+30% upside vs the anchor close.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -0.9.
What can break
Clinical misses, delayed regulatory progress, or dilutive financing could compress value by >25%, reflecting small-cap binary risk.
Momentum
11
Value
37
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.40 · Bull $5.72 · Bear $3.30
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-07 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $12.17
Why
Momentum11 · Δ7d -11.0
Value37 · Δ7d +0.0
Sentiment68 · Δ7d -0.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
11
26% active weight
Current posture
7d trendSoftening
Δ7d
-11.0
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.1
Sentiment
68
34% active weight
Current posture
7d trendFlat
Δ7d
-0.9
Δ21d
-
Why this grade
Composite grade D. Momentum 11.2 / Value 36.5 / Sentiment 67.5
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$217.37M
Beta
0.61
Shares Out
59.88M
P/E (TTM) · Derived
-3.3
P/S (TTM)
84.96
P/FCF (TTM) · Derived
-3.34
Rev YoY
-87.3%
EPS YoY
-32.9%
Gross Margin
+98.7%
Op Margin
-2669.9%
Net Debt
-$74.08M
Current Ratio
7.03
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology